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Unveiling the structure and function of all the proteins a 
human body produces is undoubtedly a key task for us to 
better understand ourselves. Although a mission difficult to 
achieve, this apparently becomes more feasible upon the 
determination of the DNA sequence of the whole human 
genome, which was predicted to encode a total of 
20,000–25,000 proteins [1]. Recent efforts of direct (de no-
vo) protein isolation and peptide sequencing, mainly using 
liquid chromatography-tandem mass spectrometry (LC-MS/ 
MS) and in-depth bioinformatics analyses, led to the appar-
ent identification of over 17,000 proteins from large sets of 
human tissues, cell lines and body fluids [2,3]. 
Remarkably, 2,535 (~15%) of the 17,294 total human 
proteins detected by MS were found to be encoded by DNA 
sequences previously defined as non-protein coding ones, 
e.g., pseudogenes, non-coding RNAs, 5′ or 3′ untranslated 
regions, thus escaped any kind of previous notification [2]. 
Given that the direct protein isolation and identification of 
human proteins by Kim et al. [2] and Wilhelm et al. [3] was 
intrinsically incomplete, more novel proteins will be un-
doubtedly discovered in the future with further improve-
ment of methodologies. 
One outstanding unresolved issue here is that, although 
these protein profiling efforts provided direct evidences to 
confirm the presence of ~84% of the approximately 20,000 
previously annotated protein-coding genes [2], the rest 16% 
of them were left unconfirmed. They may have escaped the 
detection due to their absence or low abundance in the test-
ed samples, or being inaccessible to mass spectrometry 
analysis which relies on the protein digestion with limited 
choices of proteases, or none-existence (i.e., of incorrect 
prediction). The direct confirmation of these putative pro-
teins that failed the detection by these first rounds of at-
tempts is certainly highly desired but greatly challenging. 
More noteworthy is the fact that approximately 16 mil-
lion out of the 25 million peptide mass spectra obtained 
failed to match any of the human proteins hitherto annotated 
[2]. After an expanded search, although a small portion of 
these 16 million peptides were matched to the human ge-
nome sequence, leading to the discovery of 2,535 novel 
protein-coding genes. Nevertheless, still a tremendous 
number of these detected peptides, assuming to be real, 
await to be matched to proteins encoded by the human ge-
nome. The detection of such a great number of ‘orphan’ 
peptides apparently indicates that many more polypeptides 
might be encoded, transcribed, translated or modified in the 
human body via currently unknown mechanisms. It follows 
that the grammar we so far learned about the DNA language 
of the human genome is far from complete and we have   
to find new ways to read it, as attempted by Vanderperre  
et al. [4]. 
Without doubt, to work out the full picture of the human 
proteome we still have a long way to go. The parallel Hu-
man Protein Altas project seeks to generate antibodies for 
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each of the predicted putative human proteins using the in-
formation of their predicted amino acid sequences, and then  
apply the antibodies to detect whether the putative proteins 
actually exist in human samples [5]. This antibody-based 
approach, though serving as a parallel and likely more de-
finitive way to demonstrate whether those annotated human 
proteins are genuine, would be hardly effective in finding 
out the missing proteins to which this large number of un-
matched ‘orphan’ peptides might be derived from. In this 
regard, one potential way to demonstrate from what human 
protein these unmatched peptides are derived is to make 
antibodies against these putative peptides and use them to 
examine the human samples. But this approach would at 
best only be partially effective, because usually only one 
peptide sequence is available for antibody production for 
each putative protein (multiple of these peptides might be 
derived from one single protein, but this information is not 
known beforehand), whereas at least two antibodies each of 
which binds to a different epitope would be desired for de-
tecting one putative protein [5].  
In contrast to the Human Genome, which is largely iden-
tical in each of our cells and thus a clear finish line can be 
drawn for its complete sequencing, we are not clear where 
the end point is for gaining a full picture of the human pro-
teome, which differs in each different type of cells and tis-
sues, and during different developmental stages or under 
various life conditions. To make things worse, many human 
proteins are produced in extremely low abundance, and/or 
only in a rather dynamic time- and space-dependent manner. 
Without doubt, the identification and characterization of all 
the proteins that the human body produces is certainly a 
mission difficult to achieve, if achievable at all [6]. 
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